Gamma secretase inhibitor enhances sensitivity to doxorubicin in MDA-MB-231 cells.
about
Effect of miR-155 knockdown on the reversal of doxorubicin resistance in human lung cancer A549/dox cells.VEGFR3 inhibition chemosensitizes lung adenocarcinoma A549 cells in the tumor-associated macrophage microenvironment through upregulation of p53 and PTEN.Combined drug therapeutic strategies for the effective treatment of Triple Negative Breast Cancer.Positive feedback loop between mitochondrial fission and Notch signaling promotes survivin-mediated survival of TNBC cells
P2860
Gamma secretase inhibitor enhances sensitivity to doxorubicin in MDA-MB-231 cells.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Gamma secretase inhibitor enhances sensitivity to doxorubicin in MDA-MB-231 cells.
@ast
Gamma secretase inhibitor enhances sensitivity to doxorubicin in MDA-MB-231 cells.
@en
type
label
Gamma secretase inhibitor enhances sensitivity to doxorubicin in MDA-MB-231 cells.
@ast
Gamma secretase inhibitor enhances sensitivity to doxorubicin in MDA-MB-231 cells.
@en
prefLabel
Gamma secretase inhibitor enhances sensitivity to doxorubicin in MDA-MB-231 cells.
@ast
Gamma secretase inhibitor enhances sensitivity to doxorubicin in MDA-MB-231 cells.
@en
P2093
P2860
P1476
Gamma secretase inhibitor enhances sensitivity to doxorubicin in MDA-MB-231 cells.
@en
P2093
Cheng Wang
Sheng-Chun Liu
P2860
P304
P577
2015-05-01T00:00:00Z